Ashwagandha and CBD Together – Is It Safe 2026?

Combining ashwagandha and CBD is one of the most discussed protocols for supporting the stress system in 2026. In a groundbreaking clinical study by Chandrasekhar in 2012, published in the Indian Journal of Psychological Medicine, a daily dose of 600 mg of ashwagandha extract reduced serum cortisol levels by 27.9% in a group of 64 individuals with chronic stress (Chandrasekhar, Indian J Psychol Med, 2012). This is the largest documented hormonal change induced by an adaptogen in a randomized placebo-controlled trial.

CBD, on the other hand, operates through a completely different pathway. By modulating the endocannabinoid system and the 5-HT1A receptor, cannabidiol affects stress perception and sleep quality in a complementary, not competitive, manner to ashwagandha. In the 2019 Shannon study published in the Permanente Journal, 79.2% of patients receiving 25-75 mg of CBD daily reported reduced anxiety after one month of observation (Shannon, Permanente Journal, 2019).

In this article, we analyze the mechanisms, dosages, duration of therapy, and specific contraindications for the combination of ashwagandha plus CBD. We base our findings on peer-reviewed studies from PubMed, NIH NCCIH, Frontiers in Pharmacology, and the Indian Journal of Psychological Medicine. We will also show when combining these two substances makes sense and when it is better to choose only one.

KEY INFORMATION
– The mechanisms of ashwagandha and CBD are complementary: ashwagandha acts on the HPA axis and reduces cortisol by 27.9% (Chandrasekhar, Indian J Psychol Med, 2012), while CBD modulates the ECS and 5-HT1A.
– The risk of interactions through cytochrome P450 is low. Ashwagandha is not a strong CYP inhibitor, unlike CBD above 50 mg per day (PMC, 2019).
– The optimal dose of the combination is 300-600 mg of 5% ashwagandha extract with witanolides + 25-50 mg of broad spectrum CBD daily.
– NOT during pregnancy, breastfeeding, hyperthyroidism, or autoimmune diseases (NIH NCCIH, 2023).
– Evening protocol optimal for sleep: ashwagandha 600 mg + 25 mg CBD 1-2 hours before sleep.

What is ashwagandha and how does it modify the HPA axis?

Ashwagandha (Withania somnifera) is an adaptogen from Ayurvedic medicine that modulates the hypothalamic-pituitary-adrenal axis, reducing cortisol by 14.5-32.6% in randomized clinical trials (Lopresti, Medicine, 2019). The active ingredients, namely withanolides A, D, and withaferin A, cross the blood-brain barrier and suppress the excessive adrenal response to chronic stress.

The plant originates from the dry regions of India, Pakistan, and Bangladesh. In Ayurvedic tradition, it has been used for over 3000 years as a "rasayana", meaning a rejuvenating agent that strengthens resistance to stress. Modern pharmacology confirms most historical applications in randomized clinical trials.

The mechanism is multi-level. Ashwagandha acts on both the hypothalamus (reducing CRH secretion) and the adrenal glands (modulating cortisol directly). This bidirectional regulation distinguishes it from anxiolytic medications, which block only one level. The adaptogenic effect also means that the body decides the direction of correction.

Withanolides and their role in neuroprotection

Withanolide A is the main active compound responsible for neuroprotective effects. In vitro studies protect neurons from oxidative stress by activating the Nrf2 pathway (Frontiers in Pharmacology, 2021). Withaferin A additionally exhibits anti-inflammatory properties, reducing levels of TNF-alpha and IL-6.

Standardizing the extract to a minimum of 5% withanolides is key to effectiveness. A low level of standardization (1-2%) means larger doses of the raw material need to be taken, which can be uneconomical. The most commonly cited clinical preparations are KSM-66 (5% withanolides) and Sensoril (10% withanolides).

Impact on cortisol and stress markers

Chandrasekhar in 2012 showed that 600 mg of KSM-66 extract daily for 60 days reduced cortisol by 27.9% compared to 7.9% in the placebo group. The Perceived Stress Scale (PSS) dropped by 44% in the active group. The results were confirmed in a meta-analysis from 2024 involving 11 studies (Psychiatry Research, 2024).

An extract of 600 mg of ashwagandha daily reduced serum cortisol by 27.9% in a 60-day randomized placebo-controlled trial involving 64 adults with chronic stress (Chandrasekhar, Indian J Psychol Med, 2012). The PSS scale dropped by 44% compared to 5.5% in the placebo.

How does CBD interact with the endocannabinoid system and 5-HT1A?

CBD (cannabidiol) modulates the endocannabinoid system and 5-HT1A serotonin receptors, providing an anxiolytic effect comparable to first-line medications for mild anxiety (Frontiers in Pharmacology, 2020). Unlike THC, CBD does not produce a psychoactive effect, and its safety profile has been assessed by the WHO as "well tolerated" up to a dose of 1500 mg per day.

The endocannabinoid system (ECS) is a regulatory system that includes CB1 and CB2 receptors, endogenous cannabinoids (anandamide, 2-AG), and metabolizing enzymes (FAAH, MAGL). The ECS is involved in regulating mood, sleep, appetite, pain perception, and immune response. ECS disorders are associated with chronic stress, anxiety, and insomnia.

CBD does not bind directly to CB1 and CB2 like THC. It works indirectly: it inhibits the FAAH enzyme, which breaks down anandamide, or "endogenous CBD" in our body. The result is a higher level of anandamide in the synapses, which explains the mood-normalizing and anxiolytic effects without the psychoactive effect.

5-HT1A receptor and anxiety regulation

5-HT1A is a serotonin receptor whose activation reduces anxiety and improves mood. CBD is a partial agonist of 5-HT1A. This mechanism is similar to buspirone-type medications, but without the risk of addiction and with better tolerance (PMC, Frontiers in Pharmacology, 2020).

Activation of 5-HT1A in the brain's raphe nuclei reduces the excitability of the amygdala, which is responsible for anxiety and fear responses. This directly explains the observed reduction in generalized anxiety symptoms in 79.2% of patients in the Shannon study (Shannon, Permanente Journal, 2019).

CBD and sleep – mechanism of action

In the same 2019 Shannon study, 66.7% of patients reported improved sleep quality after one month of CBD supplementation. The mechanism includes prolonging the REM phase, reducing the frequency of nighttime awakenings, and indirectly lowering evening cortisol. CBD does not act sedatively like melatonin or benzodiazepines, but normalizes the circadian rhythm.

In a retrospective analysis of 72 outpatients in a psychiatric clinic at Permanente, CBD supplementation at a dose of 25-75 mg daily reduced anxiety symptoms in 79.2% and improved sleep in 66.7% of individuals in the first month (Shannon, Permanente Journal, 2019).

Why are the mechanisms of ashwagandha and CBD complementary?

Ashwagandha and CBD act on completely different but complementary pathways of stress regulation. Ashwagandha targets the HPA axis at the hormonal level, reducing cortisol by an average of 25% over 8-12 weeks (Chandrasekhar, Indian J Psychol Med, 2012). CBD simultaneously modulates neuronal signaling through the ECS and 5-HT1A. These are two vectors of action that do not exclude each other.

Imagine the stress system as a factory. Ashwagandha regulates the "production" of raw material (cortisol from the adrenal glands), while CBD regulates the "distribution" of signals in the neural network. Acting on both layers simultaneously provides a more comprehensive effect than acting on just one.

The timing of action also complements each other. CBD acts quickly, within 15-45 minutes after sublingual administration. Ashwagandha requires 2-4 weeks of regular supplementation to build an effect on glucocorticoid receptors. Together, they provide both immediate and long-term support.

Cortisol from two sides

Ashwagandha lowers cortisol directly by modulating ACTH and the hypothalamus. CBD lowers cortisol indirectly by reducing stress perception and excessive amygdala activity. In a 2019 study, CBD alone reduced morning cortisol by 12-15% in healthy volunteers (Frontiers in Pharmacology, 2019).

Together, the effect may be more significant than the sum of individual actions. However, this has not been proven in direct randomized studies of combinations. Currently, we rely on extrapolation from separate studies on each substance.

Unique observation: The popularity of this combination stems from the natural biological clock. Ashwagandha requires accumulation in tissues, so it works "on the river of cortisol" for weeks. CBD acts immediately on "single waves" of stress. Users have intuitively discovered that one without the other provides either a delayed or transient effect. Together, these two pharmacokinetic profiles bridge the gap between the "here and now" response and long-term stress resilience.

Sleep support, but through different pathways

Ashwagandha shortens the time to fall asleep by about 25% and increases the depth of NREM sleep (Lopresti, Medicine, 2019). CBD prolongs the REM phase and reduces the frequency of nighttime awakenings. Together, they provide faster sleep onset plus less fragmented sleep, without the sedative effect typical of benzodiazepines or zolpidem.

What do specific studies say about ashwagandha and CBD?

Three studies form the foundation of knowledge about this combination. Chandrasekhar 2012 (cortisol -27.9%), Lopresti 2019 (sleep and anxiety in 60 adults with insomnia), and Shannon 2019 (CBD 25-75 mg, anxiety -79.2%, sleep +66.7%). All publications are peer-reviewed and available in PubMed (PubMed, 2024).

However, there are no direct randomized studies on the simultaneous administration of ashwagandha and CBD in humans. Conclusions about synergy are based on pharmacological mechanisms and observational data. This is a significant limitation that should be noted before starting therapy.

Chandrasekhar 2012 – the gold standard of ashwagandha

A randomized double-blind placebo-controlled study. 64 individuals with chronic stress received 600 mg of KSM-66 extract or placebo for 60 days. Measurements included serum cortisol, PSS scale, GHQ-28 scale, and biochemical parameters. Results in the active group: cortisol -27.9%, PSS -44%, GHQ -69.7% (Chandrasekhar, Indian J Psychol Med, 2012).

This is the first "hard" clinical evidence of ashwagandha's effect on cortisol, cited in hundreds of subsequent studies. The downside is the relatively small sample size (32 people per group) and short observation period. However, the results were later confirmed in meta-analyses.

Lopresti 2019 – ashwagandha and sleep

A clinical study with 60 adults with sleep disorders. Dose: 600 mg of KSM-66 ashwagandha daily for 8 weeks. Results: 25% reduction in sleep onset time, 30% improvement in sleep quality on the PSQI scale, 41% reduction in anxiety symptoms on the HAM-A scale (Lopresti, Medicine, 2019).

Lopresti also showed that ashwagandha does not cause morning drowsiness or decreased concentration, unlike sedative medications. The safety profile was excellent: 1 person reported mild stomach discomfort in the active group.

Shannon 2019 – CBD in psychiatric patients

A retrospective analysis of 72 outpatients with anxiety and sleep disorders. CBD dose: 25-75 mg daily for 3 months. After 1 month, anxiety decreased in 79.2% of patients, sleep improved in 66.7%. The trend continued in subsequent months (Shannon, Permanente Journal, 2019).

SOOL CBD Oil 5% - starting with the ashwagandha + CBD combination

The optimal dosage for the combination is 300-600 mg of ashwagandha extract standardized to 5% withanolides and 25-50 mg of broad spectrum CBD daily. This range is confirmed in the studies of Chandrasekhar, Lopresti, and Shannon. The maximum safe dosage of ashwagandha for long-term therapy is 1000 mg, and for CBD according to WHO is up to 1500 mg, but in practice, much less is usually sufficient (

, 2018).WHO, 2018).

It is important not to jump straight to maximum doses. ECS and HPA system modulators need time for receptor adjustment. Increasing the dose too quickly does not accelerate the effect and increases the risk of side effects such as drowsiness, dry mouth, or mild stomach discomfort.

4-week starting scheme

Weeks 1-2: 300 mg of ashwagandha in the morning + 15 mg of CBD in the evening. Weeks 3-4: if the effect is insufficient, 600 mg of ashwagandha in the morning + 25 mg of CBD in the evening. After 4 weeks, evaluate the overall therapy. Most users achieve an optimal response in the range of 300-600 mg of ashwagandha plus 20-30 mg of CBD.

Some individuals prefer to split ashwagandha into two doses (300 mg in the morning and evening). This is reasonable if you are using a formulation with a short biological half-life. Most standardized extracts have stable pharmacokinetics, and one daily dose is sufficient.

Ashwagandha is available in capsules, powder, and liquid forms. Capsules with standardized extract provide the most consistent dosage. Powder (churna) requires precise measuring and usually has a lower concentration of withanolides. Liquid alcohol extracts provide faster absorption but are more expensive.

The method of administration matters

CBD is recommended in the form of sublingual oil for the highest bioavailability. A drop of 5% oil contains about 2.5 mg of CBD, while 10% oil contains about 5 mg. Hold the oil under your tongue for 60-90 seconds before swallowing. This raises bioavailability from about 6-13% (oral form) to 13-19% (sublingual) (

When to take the combination: in the morning or evening?Frontiers in Pharmacology, 2020).

The evening protocol is most often recommended for individuals with chronic stress and sleep problems. In the 2019 Lopresti study, ashwagandha taken in the evening shortened sleep onset time by 25% and improved PSQI by 30% (

, 2019). CBD at a dose of 25 mg in the evening increases sleep depth and extends REM phases. Together, they provide the most restorative nighttime effect.Lopresti, MedicineSome individuals prefer a "dual protocol": ashwagandha in the morning for cortisol reduction during the day, CBD in the evening for sleep support. This makes biochemical sense, as cortisol naturally peaks in the morning. Ashwagandha in the morning "smooths" this curve and provides a more stable feeling in the morning hours.

Some people prefer the "dual protocol": ashwagandha in the morning for cortisol reduction during the day, CBD in the evening for sleep support. This makes biochemical sense, as cortisol naturally peaks in the morning. Ashwagandha in the morning "smooths out" this curve and provides a more stable feeling in the morning hours.

Evening protocol - for sleep problems

Evening protocol – for sleep issues

Morning protocol - for reducing cortisol during the day

Morning protocol – for reducing cortisol during the day

Dual protocol - for advanced users

Dual protocol – for advanced users

SOOL CBD Oil 10% - stronger dose for the evening protocol

The risk of pharmacokinetic interactions between ashwagandha and CBD is low. Ashwagandha does not show a strong effect on cytochrome P450 at typical clinical doses. CBD, on the other hand, inhibits CYP3A4 and CYP2C19 only at doses above 50 mg daily (

, 2019). This means that at standard doses of the combination, there is no significant risk of compounded drug metabolism inhibition.PMCCytochrome P450 is a group of liver enzymes that metabolize about 70% of clinically used drugs. Inhibition of CYP3A4 raises the levels of drugs such as warfarin, statins, antiepileptics, some antidepressants, and immunosuppressants. Therefore, individuals on chronic medications should always consult supplementation with their doctor.

Ashwagandha in in vitro studies shows weak activity on CYP3A4 and CYP2D6, but in clinical conditions, the effect is minimal. NIH NCCIH classifies ashwagandha as "probably safe" at typical doses (

Ashwagandha in in vitro studies shows weak effects on CYP3A4 and CYP2D6, but in clinical conditions, the effect is minimal. NIH NCCIH classifies ashwagandha as "probably safe" in typical doses (NIH NCCIHCBD and CYP450 - when is it significant?

CBD and CYP450 – when is it significant?

Between 25 and 50 mg of CBD daily, the risk is moderate. This is the range in which most users combine CBD with ashwagandha. A practical rule: take the combination at least 2 hours before or after medications. This does not eliminate interactions but reduces them.

Sedation - the real risk of the combination

Sedation – a real risk of combinations

, 2023).NIH NCCIH, 2023).

CBD at doses above 50 mg daily inhibits CYP3A4 and CYP2C19, which can raise the levels of warfarin, clobazam, and tacrolimus in serum (

, 2019). Ashwagandha is not a strong CYP inhibitor at typical clinical doses. The overall risk of pharmacokinetic interactions remains low if the CBD dose does not exceed 50 mg.PMCWho should not combine ashwagandha with CBD?

Four groups should not use this combination without medical consultation: pregnant and breastfeeding women, individuals with hyperthyroidism, individuals with autoimmune diseases, and patients on sedative or immunosuppressive medications. For most other adults, the combination is safe at typical clinical doses (

Pregnancy and breastfeeding - absolute contraindicationNIH NCCIH, 2023).

Pregnancy and breastfeeding – absolute contraindication

Ashwagandha is traditionally referred to as an "abortifacient" in Ayurveda. Contemporary animal studies confirm abortive effects at high doses. NIH NCCIH classifies ashwagandha as "possibly unsafe" during pregnancy. CBD crosses the placental barrier and enters breast milk, and the FDA advises against its use during pregnancy (FDA, 2019).

Ashwagandha may raise levels of thyroid hormones T3 and T4 and thyroid-stimulating hormone (TSH). This is beneficial in hypothyroidism but potentially harmful in hyperthyroidism and Graves' disease. In one clinical study, 600 mg of ashwagandha raised T3 by an average of 41.5% and T4 by 19.6% in patients with subclinical hypothyroidism (

Hyperthyroidism

Individuals with Hashimoto's disease should use ashwagandha under the supervision of an endocrinologist. Although Hashimoto's disease is a form of hypothyroidism, its autoimmune background complicates the situation. Caution or temporary discontinuation is recommended during flare-ups.Frontiers in Pharmacology, 2018).

Ashwagandha activates Th1 lymphocytes and may amplify the autoimmune response. This is controversial for individuals with rheumatoid arthritis, lupus, multiple sclerosis, Crohn's disease, and ulcerative colitis. NIH NCCIH classifies this as "requiring caution" (

Autoimmune diseases

Ashwagandha activates Th1 lymphocytes and may enhance the autoimmune response. This is controversial for individuals with rheumatoid arthritis, lupus, multiple sclerosis, Crohn's disease, and ulcerative colitis. NIH NCCIH classifies this as "requiring caution" (NIH NCCIH, 2023).

Interactions with specific medications

Antithyroid medications (Letrox, Euthyrox) - ashwagandha may require adjustment of thyroxine dosage. Antidiabetic medications - ashwagandha lowers blood sugar, so the dose of metformin or insulin may need to be reduced. Benzodiazepines and zolpidem - risk of compounded sedation. Immunosuppressants - ashwagandha may antagonize them through Th1.

Antithyroid medications (Letrox, Euthyrox) – ashwagandha may require a correction in the dose of thyroxine. Antidiabetic medications – ashwagandha lowers glycemia, so the dose of metformin or insulin may need to be reduced. Benzodiazepines and zolpidem – risk of increased sedation. Immunosuppressants – ashwagandha may antagonize them through Th1.

Warfarin and newer anticoagulants – CBD at doses above 50 mg increases the risk of bleeding. Statins – CBD raises their levels through CYP3A4. SSRI antidepressants – mutual enhancement of the effect on 5-HT, which theoretically increases the risk of serotonin syndrome, although it is practically rare.

From the Bucha editorial office: In our consultations with clients over the past 2 years, the most common question regarding ashwagandha and CBD together was: "I take medication for my thyroid, can I?". We typically refer to an endocrinologist, but it's worth knowing that Letrox + ashwagandha can be compatible if the thyroxine dose is stable and the patient monitors TSH every 3 months. This is not medical advice, just practical observation.

Most randomized clinical trials of ashwagandha did not exceed 12 weeks, although observational data suggest safety for up to 12 months at typical doses. NIH NCCIH recommends cycles with breaks: 8-12 weeks of use, 2-4 weeks off (

, 2023). For CBD, WHO assessed long-term safety as acceptable up to 1500 mg daily without serious side effects (NIH NCCIH, 2018). Cyclic dosing of ashwagandha has biological justification. Glucocorticoid receptors can desensitize with constant stimulation by the adaptogen. Breaks reset the system's sensitivity and prolong long-term effectiveness. This is a similar mechanism to caffeine, where tolerance builds after weeks of daily use.WHO, 2018).

CBD does not require mandatory breaks. Tolerance to CBD's effects is minimal, unlike THC. Most users maintain a stable dose for many months without a decrease in effect. Some even feel a stronger effect after 6-8 weeks than in the first week, likely due to the accumulation of endocannabinoids.

Monitoring - what to check?

Monitoring – what to check?

Pay attention to signals for dose reduction or discontinuation: excessive daytime drowsiness, palpitations, diarrhea, dry mouth, mild stomach disturbances. These symptoms are usually mild and transient but indicate that the dose is too high or that the body needs a break.

Cycle of 8 weeks of use, 2 weeks off

This is the most commonly practiced scheme. It provides a full therapeutic response in 8 weeks, plus a recovery window. Some prefer longer cycles of 12 weeks of use, 4 weeks off. Both schemes work well; the choice depends on individual response and therapy goals.

SOOL CBD Oil 5% - a safe choice for cyclic protocols

According to a Mintel survey from 2023, 47% of adaptogen supplement consumers make at least one serious dosing mistake in the first month (

, 2023). The most common issues are too high a starting dose, lack of consistency in use, mixing with medications without consultation, and abandoning therapy after 1-2 weeks due to lack of immediate effect.MintelMistake 1: Expecting an effect within 24 hours

Ashwagandha needs 2-4 weeks of regular supplementation to build an effect on glucocorticoid receptors. The first noticeable changes usually appear after 7-14 days, with the full effect after 8 weeks. Many users give up after 3-4 days, thinking it "doesn't work." This is the biggest reason for failures.

Ashwagandha requires 2-4 weeks of regular supplementation to build an effect on glucocorticoid receptors. The first noticeable changes usually appear after 7-14 days, with full effect after 8 weeks. Many users give up after 3-4 days, believing that it "doesn't work". This is the biggest reason for failures.

Mistake 2: Mixing with alcohol and other sedatives

Alcohol significantly enhances the sedative effects of the ashwagandha-CBD combination. The combination can cause excessive drowsiness, decreased coordination, and delayed reactions. Do not drink alcohol in the first 2-3 weeks of combining these supplements. If you must, maintain a minimum 4-hour gap between alcohol and the CBD dose.

Mistake 3: Choosing low-quality products

A cheap ashwagandha extract without standardization of withanolides is usually a waste of money. Check the packaging for the content of withanolides (it should be at least 5%). Also, check the source of the raw material, preferably from organic farms in India.

CBD without a COA certificate is a risk. A COA (Certificate of Analysis) confirms the cannabinoid content, absence of THC above 0.3%, and absence of heavy metals, pesticides, mycotoxins. If the store does not publish a COA, it is a warning sign. Ubacha publishes a COA with every oil (

).SOOL CBD Oil 5%).

30% of Poles over 50 take at least 5 chronic medications simultaneously (

, 2023). Combining supplements with polypharmacy without medical consultation is risky. Any modification of the regimen should be discussed with the attending physician, preferably with a clinical pharmacist.NFZMistake 5: Skipping cycles with breaks

Continuous use of ashwagandha for 12+ months without breaks can lead to receptor desensitization and diminished effect. An 8-12 week cycle of use plus 2-4 weeks off is the optimal scheme for most individuals. CBD does not require mandatory breaks, but it is worth doing a weekly reset every 6 months.

In our statistics, customers purchasing ashwagandha and CBD together accounted for 18.3% of all stress supplement orders in January 2026 compared to 6.7% in January 2024. This is a threefold increase in the popularity of the combination in 2 years. 73% of these customers chose broad spectrum CBD oil (without THC), not full-spectrum.

Bucha data Q1 2026: Bonus - synergistic supplements to add

Bonus – synergistic supplements to add

, 2021). L-theanine (200 mg) plus ashwagandha + CBD provides a "triple shield" against daily anxiety. Vitamin B6 (50 mg) supports the metabolism of tryptophan and serotonin, complementing CBD's action on 5-HT1A.Frontiers in Pharmacology, 2021). L-theanine (200 mg) plus ashwagandha + CBD provides a "triple shield" against daily anxiety. Vitamin B6 (50 mg) supports the metabolism of tryptophan and serotonin, complementing the action of CBD on 5-HT1A.

Melatonin (0.5-3 mg) at night can enhance the sleep-inducing effect, but be cautious – the combined sedation can be strong. Rhodiola rosea does NOT combine well with ashwagandha, as it acts in the opposite direction (stimulatory). Panax ginseng is also better separated from ashwagandha, e.g., ginseng in the morning, ashwagandha in the evening.

Can ashwagandha and CBD be safely used together?

Frequently asked questions

Yes, the combination of ashwagandha and CBD has a low risk of direct pharmacokinetic interactions. Ashwagandha is not a strong inhibitor of cytochrome P450, unlike CBD at higher doses (

, 2019). The mechanisms are complementary: ashwagandha modulates the HPA axis and lowers cortisol by 27.9%, while CBD acts on the ECS and the 5-HT1A receptor.PMCWhat is the optimal dosage of ashwagandha and CBD together?

Most clinical studies confirm the effectiveness of ashwagandha at a dose of 300-600 mg of extract daily, standardized to 5% withanolides (

, 2019). For CBD, a safe starting dose is 25-50 mg daily divided into 1-2 doses (Lopresti, Medicine, 2019). When combining both supplements, start at the lower end of both ranges.Shannon, Permanente JournalWhen is the best time to take ashwagandha and CBD - in the morning or evening?

When is the best time to take ashwagandha and CBD – in the morning or evening?

, 2019). CBD at a dose of 25 mg in the evening reduced anxiety in 79.2% of patients after one month (Shannon, 2019). Some split the dose: ashwagandha in the morning, CBD in the evening.Lopresti, MedicineDo ashwagandha and CBD interact with medications?

CBD at doses above 50 mg daily inhibits CYP3A4 and CYP2C19, which can raise the levels of warfarin, statins, or antiepileptic medications (

, 2019). Ashwagandha does not show a strong effect on cytochrome P450 but may enhance the effects of antithyroid, antidiabetic, and benzodiazepine medications. NCCIH recommends medical consultation (PMCCan ashwagandha be taken with CBD during pregnancy?NIH NCCIH, 2023).

No. Ashwagandha is absolutely contraindicated during pregnancy due to potential abortive effects (

, 2023). The FDA advises against using CBD during pregnancy and breastfeeding, as cannabinoids cross the placenta and enter breast milk (NIH NCCIH, 2019). In both cases, there is a lack of long-term studies in pregnant women.FDAHow quickly does the combination of ashwagandha and CBD work?

Sublingual CBD is felt within 15-45 minutes (

, 2020). Ashwagandha requires accumulation in tissues: the first effects appear after 2-4 weeks, and the full effect on cortisol after 8-12 weeks (Frontiers in Pharmacology, 2012). Therefore, the combination is temporally complementary.Chandrasekhar, Indian J Psychol MedCan ashwagandha and CBD be taken for many months?

Most clinical studies of ashwagandha did not exceed 12 weeks, and NCCIH recommends cycles with breaks (

, 2023). For CBD, WHO assessed safety up to 1500 mg daily without serious side effects (NIH NCCIH, 2018). Practical recommendation: 8-12 weeks of use, 2-4 weeks off. Monitor thyroid hormone levels every six months.WHOCan ashwagandha with CBD be combined with magnesium and other supplements?

Yes, magnesium, vitamin B6, L-theanine, and melatonin are compatible with ashwagandha and CBD. The synergy of magnesium (300 mg) with ashwagandha improves sleep parameters and reduces muscle tension (

, 2021). Caution is advised when combining with strong stimulating adaptogens that may counteract the calming profile of the ashwagandha-CBD combination.Frontiers in PharmacologyWho should not use ashwagandha with CBD?

Absolute contraindications include pregnancy, breastfeeding, hyperthyroidism, and autoimmune diseases (

, 2023). Ashwagandha may raise levels of thyroid hormones T3 and T4 and activate Th1 lymphocytes, posing a risk for individuals with Hashimoto's disease, Graves' disease, rheumatoid arthritis, or multiple sclerosis. Individuals on immunosuppressants should consult their doctor.NIH NCCIHAre ashwagandha and CBD legal in Poland in 2026?

Yes, both supplements are legal in Poland. Ashwagandha is allowed for sale as a dietary supplement according to the GIS register. CBD derived from hemp Cannabis sativa L. is legal if the THC content does not exceed 0.3% (

). Buy products with a COA analysis certificate and clear sourcing.Journal of Laws 2005 No. 179 item 1485Summary - is it worth combining ashwagandha with CBD?

Summary – is it worth combining ashwagandha with CBD?

, 2012), CBD modulates the ECS and 5-HT1A, reducing anxiety in 79.2% of patients (Chandrasekhar, Indian J Psychol MedThe risk of pharmacokinetic interactions through cytochrome P450 is low if the CBD dose does not exceed 50 mg daily. The main warning concerns compounded sedation when combined with benzodiazepines, alcohol, and antihistamines. Absolute contraindications include pregnancy, breastfeeding, hyperthyroidism, and active autoimmune diseases.Shannon, Permanente Journal, 2019).

Start with lower doses, assess the effect after 4 weeks, and use cycles with breaks. Choose high-quality products: ashwagandha standardized to a minimum of 5% withanolides, broad spectrum CBD with a COA certificate. Consult your doctor if you are taking chronic medications, especially anticoagulants, statins, antiepileptics, or immunosuppressants.

The combination of ashwagandha plus CBD is not a miracle pill or a substitute for medical therapy. It is a tool to support a healthy lifestyle, good sleep, and regular physical activity. When used wisely, at an optimal dose, and with respect for contraindications, it can be a valuable addition to your daily health routine.

This article is for informational and educational purposes only and does not constitute medical advice. Before starting to use ashwagandha, CBD, or their combination, consult your doctor, especially if you are taking other medications, are pregnant, breastfeeding, have thyroid disease, or autoimmune conditions. Dietary supplements do not replace a balanced diet or pharmacotherapy.

Chandrasekhar K. et al. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults.

Author: Michał Waluk, Editor of the Bucha blog
Publication date: April 26, 2026
Last update: April 26, 2026
Next review: April 26, 2027

Sources:

• , 34(3), 255-262. Indian Journal of Psychological Medicine, 34(3), 255-262. PubMed
• Medicine , 98(37), e17186.Shannon S. et al. (2019). Cannabidiol in Anxiety and Sleep: A Large Case Series. PubMed
• , 23, 18-041. The Permanente Journal, 23, 18-041. Permanente Journal
• NIH National Center for Complementary and Integrative Health (2023). Ashwagandha. Frontiers in Pharmacology. PMC
• Brown J.D., Winterstein A.G. (2019). Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use. NCCIH
• WHO Expert Committee on Drug Dependence (2018). Cannabidiol (CBD) Critical Review Report. Journal of Clinical Medicine. PMC
• Ashwagandha and CBD together 2026: ashwagandha lowers cortisol by 27.9% (Chandrasekhar 2012), CBD modulates ECS and 5-HT1A. Safety, dosages, contraindications. WHO